Yu Heng Kwan Selected Research

Yu Heng Kwan Research Topics

8	Ankylosing Spondylitis 01/2023 - 10/2017
6	Pain (Aches) 04/2020 - 12/2016
5	Axial Spondyloarthritis 12/2021 - 05/2018
3	Hypertension (High Blood Pressure) 04/2024 - 01/2019
2	Uveitis 01/2023 - 08/2019
2	COVID-19 01/2023 - 04/2022
2	Neoplasms (Cancer) 03/2022 - 01/2019
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 11/2019
2	Stroke (Strokes) 01/2021 - 01/2020
2	Acute Coronary Syndrome 11/2020 - 11/2020
2	Chronic Renal Insufficiency 11/2019 - 01/2019
2	Osteoarthritis 04/2018 - 11/2017
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023
1	Chronic Disease (Chronic Diseases) 04/2022
1	Hyperaldosteronism (Conn Syndrome) 07/2021
1	Coronary Disease (Coronary Heart Disease) 01/2021
1	Hemorrhage 11/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2020
1	Myocardial Infarction 01/2020
1	Non-Radiographic Axial Spondyloarthritis 08/2019
1	Arthritis (Polyarthritis) 07/2019
1	Death (Near-Death Experience) 01/2019
1	ST Elevation Myocardial Infarction 01/2019
1	Rheumatic Diseases (Rheumatism) 04/2018
1	Rhabdomyolysis 12/2017
1	Obesity 10/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2016
1	Congenital Abnormalities (Deformity) 01/2016
1	Thrombocytopenia (Thrombopenia) 09/2015

4	C-Reactive ProteinIBA 12/2019 - 05/2018
3	Prostaglandins AIBA 04/2020 - 12/2016
3	ametantrone (HAQ)IBA 03/2018 - 12/2016
2	Cytochrome P-450 CYP2C19IBA 11/2020 - 11/2020
2	LipidsIBA 11/2019 - 01/2019
1	SDMIBA 04/2024
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2023
1	Antirheumatic Agents (DMARD)IBA 01/2023
1	Serum AlbuminIBA 03/2022
1	CreatinineIBA 03/2022
1	Clopidogrel (Plavix)FDA Link 11/2020
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 08/2019
1	HLA Antigens (Human Leukocyte Antigens)IBA 08/2019
1	11,14-dihydroxypregn-4-ene-3,20-dioneIBA 07/2019
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2019
1	insulin receptor-related receptor (IRR)IBA 01/2019
1	TransferasesIBA 12/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2017
1	Aspartic Acid (Aspartate)FDA Link 12/2017
1	Biomarkers (Surrogate Marker)IBA 12/2017
1	Transaminases (Aminotransferases)IBA 12/2017
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2017

2	Patient Discharge 01/2023 - 04/2022
2	Therapeutics 12/2021 - 04/2018
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 12/2021 - 01/2019
2	Surgical Amputation (Amputations) 01/2021 - 01/2020
2	Knee Replacement Arthroplasty (Total Knee Replacement) 11/2017 - 01/2016
1	Patient Transfer (Patient Dumping) 04/2022
1	Aftercare (After-Treatment) 07/2021
1	Ambulatory Care (Outpatient Care) 01/2019
1	Osteopathic Manipulation 04/2018
1	Complementary Therapies (Alternative Medicine) 04/2018
1	Orthomolecular Therapy (Megavitamin Therapy) 04/2018
1	Cardiac Rehabilitation 10/2016
1	Communication Aids for Disabled (TDD) 09/2015